Icariside II attenuates bleomycin-induced pulmonary fibrosis by modulating macrophage polarization
Dados Bibliográficos
| ID | 14745978 |
|---|---|
| Autores | Lingling Deng (0000-0002-0439-3978, Fudan University), Boshu Ouyang (0000-0002-0934-434X, Fudan University), Hanlin Shi (Fudan University), Fangyong Yang (Fudan University), Shihuan Li (0000-0002-5530-1295, Fudan University), Cong Xie (0000-0001-7269-0678, Fudan University), Wenjing Du (0000-0001-5737-6760, Fudan University), Lingli Hu (0000-0002-7684-2613, Fudan University), Ying Wei (0009-0004-9401-0855, Fudan University, autor correspondente), Jingcheng Dong (0000-0001-6674-5812), Jing-Cheng Dong (0000-0002-5194-367X, Fudan University, autor correspondente) |
| Ano | 2023 |
| Volume | 317 |
| Páginas | 116810 |
| Data de publicação | 2023-12-01 |
| Peer Reviewed | Sim |
| Open Access | Sim |
| Tipo | ARTICLE |
| Periódico | Journal of Ethnopharmacology (JOURNAL) |
| Identificadores do periódico | ISSN: 0378-8741 • E-ISSN: 1872-7573 |
| Editora | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.jep.2023.116810 |
| PMID | 37331450 |
| OpenAlex | W4380884767 |
| Idioma | EN |
| Citações recebidas | 3 |
| Referências citadas | 41 |
Bleomycin · Fibrosis · Hydroxyproline · Lung · Pathology · Pulmonary fibrosis · Cancer-related molecular mechanisms research · Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis · Medicinal Plant Pharmacodynamics Research · Medicine · Cancer Research · Internal Medicine · Pharmacology
ScRNA-sequencing Reveals Bu-Shen-Yi-Qi formula (BSYQF) ameliorates airway remodeling via regulating imbalanced M1/M2 macrophage subtypes in chronic asthmatic mice
O-rhamnosyl icariside II from Epimedium sagittatum maxim ameliorates pulmonary fibrosis by modulating the E-cadherin-mediated oxidative-epithelial mesenchymal transition axis
Fermented Cordyceps Powder alleviates silica-induced inflammation and fibrosis by inhibiting M1 macrophage polarization via the HMGB1-TLR4-NF-κB pathway
| Obras citantes distintas | 3 |
|---|---|
| Citações por ano | 3 |
| Intervalo de citações | 2025 - 2026 (2) |
| Velocidade de citação | current |
| Altamente citado | Não |
| Tipos de citação | Neutras: 3 |